Cargando…
Aripiprazole as a risk factor for impulse control disorders: a systematic review
AIMS: Aripiprazole is an anti-psychotic medication widely used for bipolar affective disorder and depression. It's primary mechanism of action is as a partial dopamine agonist. Aripiprazole's effect on dopamine signalling in the mesolimbic and mesocortical pathways may lead to impulse cont...
Autores principales: | Williams, Benjamin, Neelam, Kishen, Singh, Saumya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8769275/ http://dx.doi.org/10.1192/bjo.2021.795 |
Ejemplares similares
-
The Treatment of Adult Bipolar Disorder with Aripiprazole: A Systematic Review
por: Muneer, Ather
Publicado: (2016) -
Efficacy and safety of aripiprazole in the treatment of bipolar disorder: a systematic review
por: Fountoulakis, Konstantinos N, et al.
Publicado: (2009) -
Aripiprazole for the treatment of tic disorders in children: a systematic review and meta-analysis
por: Yang, Chun-Song, et al.
Publicado: (2015) -
A systematic review and meta-analysis of neurological soft signs in relatives of people with schizophrenia
por: Neelam, Kishen, et al.
Publicado: (2011) -
Pandemics and pre-existing mental illness: A systematic review and meta-analysis
por: Neelam, Kishen, et al.
Publicado: (2020)